DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
TETRAZEPAM
4
Small molecule
Approved
Unknown
Unknown
Unknown
GABA-A receptor; anion channel positive allosteric modulator
TETRAZEPAM
×
Maximum Phase:
4
First Approval:
None
UNII:
FO92091VP8
Molecule Type:
Small molecule
Molecular Formula:
C16H17ClN2O
Molecular Weight:
288.78
AlogP:
3.61
PSA:
32.67
HBD:
0.0
HBA:
#RotB:
1.0
Source:
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE
4
Combination
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Unknown
Unknown
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELAPEGADEMASE-LVLR
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ELAPEGADEMASE-LVLR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDIUM IN-111 PENTETATE DISODIUM
4
Small molecule
Approved
OTHER
INTRATHECAL
Unknown
Unknown
INDIUM IN-111 PENTETATE DISODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DICHLOROBENZYL ALCOHOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Sodium channel alpha subunit blocker
DICHLOROBENZYL ALCOHOL
×
Maximum Phase:
4
First Approval:
None
UNII:
1NKX3648J9
Molecule Type:
Small molecule
Molecular Formula:
C7H6Cl2O
Molecular Weight:
177.03
AlogP:
2.49
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
1.0
Source:
TRICHLOROACETIC ACID
4
Small molecule
Approved
Unknown
Unknown
Acne Vulgaris
Unknown
TRICHLOROACETIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
5V2JDO056X
Molecule Type:
Small molecule
Molecular Formula:
C2HCl3O2
Molecular Weight:
163.39
AlogP:
1.44
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
0.0
Source:
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC; TOPICAL
Unknown
Unknown
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MOROCTOCOG ALFA
4
Protein
Approved
Unknown
Unknown
Hemophilia A
Unknown
MOROCTOCOG ALFA
×
Maximum Phase:
4
First Approval:
None
UNII:
113E3Z3CJJ
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FUSIDATE SODIUM
4
Small molecule
Approved
Unknown
Unknown
Infections
Elongation factor G inhibitor
FUSIDATE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
J7P3696BCQ
Molecule Type:
Small molecule
Molecular Formula:
C31H47NaO6
Molecular Weight:
538.7
AlogP:
5.67
PSA:
104.06
HBD:
3.0
HBA:
#RotB:
5.0
Source:
ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIPENZOLATE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Unknown
PIPENZOLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
RS3K5YXV34
Molecule Type:
Small molecule
Molecular Formula:
C22H28NO3+
Molecular Weight:
354.47
AlogP:
3.09
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
5.0
Source:
UNDECOYLIUM CHLORIDE IODINE COMPLEX
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
UNDECOYLIUM CHLORIDE IODINE COMPLEX
×
Maximum Phase:
4
First Approval:
None
UNII:
O4CEK7FP0D
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROPEGINTERFERON ALFA-2B-NJFT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ROPEGINTERFERON ALFA-2B-NJFT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLOXACILLIN
4
Small molecule
Approved
Unknown
Unknown
Infections; Renal Insufficiency, Chronic; Osteomyelitis; Skin Diseases; Staphylococcal Infections; Bacterial Infections
Bacterial penicillin-binding protein inhibitor
FLOXACILLIN
×
Maximum Phase:
4
First Approval:
None
UNII:
43B2M34G2V
Molecule Type:
Small molecule
Molecular Formula:
C19H17ClFN3O5S
Molecular Weight:
453.88
AlogP:
2.69
PSA:
112.74
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PROMETHAZINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
PROMETHAZINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COLCHICINE; PROBENECID
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
COLCHICINE; PROBENECID
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCORTISONE; TETRACYCLINE HYDROCHLORIDE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
HYDROCORTISONE; TETRACYCLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LIDOCAINE; PRILOCAINE
4
Combination
Approved
OTHER
PERIODONTAL; TOPICAL
Unknown
Unknown
LIDOCAINE; PRILOCAINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SODIUM OZAGREL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SODIUM OZAGREL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC-99M EXAMETAZIME KIT
4
Small molecule
Approved
OTHER
INJECTION; INTRAVENOUS
Unknown
Unknown
TECHNETIUM TC-99M EXAMETAZIME KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMTRICITABINE;RILPIVIRINE;TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
EMTRICITABINE;RILPIVIRINE;TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE;ZIDOVUDINE;EFAVIRENZ
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE;ZIDOVUDINE;EFAVIRENZ
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IVACAFTOR; LUMACAFTOR
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
IVACAFTOR; LUMACAFTOR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LYSOZYME HYDROCHLORIDE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
LYSOZYME HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULFUR, PRECIPITATED
4
Small molecule
Approved
Unknown
Unknown
Acne Vulgaris; Pruritus
Unknown
SULFUR, PRECIPITATED
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
S
Molecular Weight:
32.07
AlogP:
0.65
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIRETANIDE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
PIRETANIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
DQ6KK6GV93
Molecule Type:
Small molecule
Molecular Formula:
C17H18N2O5S
Molecular Weight:
362.41
AlogP:
2.42
PSA:
109.93
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES
4
Unknown
Approved
OTHER
INTRAVENOUS
Unknown
Unknown
SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LACOSAMIDE
4
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
INTRAVENOUS; ORAL
Unknown
Unknown
LACOSAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLYMIDINE
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus
Unknown
GLYMIDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
4C5I4BQZ8F
Molecule Type:
Small molecule
Molecular Formula:
C13H15N3O4S
Molecular Weight:
309.35
AlogP:
1.3
PSA:
90.41
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CYANOCOBALAMIN; TANNIC ACID; ZINC ACETATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
CYANOCOBALAMIN; TANNIC ACID; ZINC ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVAMLODIPINE BESYLATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
LEVAMLODIPINE BESYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIFLUCORTOLONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DIFLUCORTOLONE
×
Maximum Phase:
4
First Approval:
None
UNII:
K253365DXI
Molecule Type:
Small molecule
Molecular Formula:
C22H28F2O4
Molecular Weight:
394.46
AlogP:
2.73
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
2.0
Source:
1
2
…
293
294
295
296
297
298
299
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA